No Picture Present
Sara Allstadt Frazier DVM, DACVIM (Oncology)
Assistant Professor
Small Animal Clinical Sciences

Professional Interests

Dr. Sara Allstadt Frazier’s research focuses on advancing novel therapeutics into clinical trials. She works to investigate therapies that advance cancer treatment and incorporate seamlessly into the clinic. She is currently investigating the thiazolidinedione class of drugs and their potential anti-cancer effects through their interaction with peroxisome proliferator activated receptors. Her publications and abstracts encompass a wide range of novel treatments and tumor types, including oral fibrosarcoma, lymphoma, and osteosarcoma, and she especially holds an interest in transitional cell carcinoma of the bladder.


  • BS Zoology, Auburn University
  • DVM at Auburn University


  • Internship in Small Animal Medicine and Surgery, Affiliated Veterinary Specialists
  • Oncology Internship, Angell Animal Medical Center
  • Residency in Oncology, University of California, Davis

Board Certification

  • Diplomate, American College of Veterinary Internal Medicine (Oncology)

Practice Experience

Dr. Frazier’s background includes both general practice, private specialty practice, and academic practice. After graduation, she practiced both large and small animal medicine and surgery in South Alabama before leaving to pursue a dream of becoming an oncologist.


  • Pharmacology (anticancer drugs)
  • Comparative and Experimental Medicine


  • Dr. Sara Allstadt Frazier received her DVM from the Auburn University in 2002. She returned to her hometown right after graduation to practice both small animal and large animal medicine and surgery. After three years in general practice, she completed a 1 year internship in small animal medicine and surgery at the Affiliated Veterinary Specialists in Maitland, Florida. She completed a one year specialty internship in oncology at Angell Animal Medical Center in Boston, MA before moving to California for her residency in oncology at the University of California-Davis. After completing her residency, she was a clinical assistant professor of oncology at the University of California-Davis for two years before joining the faculty at The University of Tennessee in 2012. She is board certified in the American College of Veterinary Internal Medicine in Oncology and serves as the oncology residency director. Dr. Frazier’s research interests include the identification of novel therapies for cancer along with the advancement of these therapies into clinical trials. She has presented her research at multiple national meetings and her publications encompass a wide range of tumor types including lymphoma, osteosarcoma, oral fibrosarcoma, mast cell tumors, and transitional cell carcinoma of the bladder.

Professional Societies

  • American College of Veterinary Internal Medicine
  • Veterinary Cancer Society
  • American Veterinary Medical Association